Pulse - Value Added
FRACTIONAL CRO · MARYLAND-BASED, NATIONWIDE · $0→$200M

Kory White

RevOps & Revenue Leadership

Get a free 30-minute revenue checkup — Kory reviews your pipeline and forecast, then names the 1–2 fixes that move revenue fastest. 25 yrs scaling teams $0→$200M.

Free 30-min revenue checkup →
Hire a Fractional CROHow We Help?LinkedInRésuméCRO Syndicate
← Library
Knowledge Library · pulse-q
13/13 Gate✓ IQ Certified10/10?

Should I open or buy an iCRYO cryotherapy franchise in 2027?

KnowledgeShould I open or buy an iCRYO cryotherapy franchise in 2027?
📖 2,107 words🗓️ Published Jun 23, 2026
Direct Answer

Yes if you want into the recovery-wellness boom at a lower capital point than Restore — iCRYO is a cryotherapy-led recovery franchise with a membership model, but it shares the same compliance considerations for IV and clinical services. iCRYO, founded in 2015 in Texas, offers whole-body cryotherapy, IV drip therapy, infrared sauna, red-light therapy, compression, and body-sculpting under a membership + à la carte model. The 2026 FDD lists a franchise fee around $40,000, total Item 7 investment of roughly $400,000 to $900,000, a royalty near 7%, and a marketing fee. Mature centers gross $500,000-$1,200,000, and owners clear $70,000-$220,000 when membership and IV services scale. iCRYO's pitch is a lower-cost, cryo-anchored entry into the same category Restore leads — with the same need for clinical compliance on IV and medical services.

The Real Numbers

An iCRYO center leases 1,800-3,500 sq ft and installs cryo chambers, IV suites, infrared sauna, red-light, and compression equipment. The model blends recurring memberships, packages, and à la carte visits, with IV therapy a higher-ticket, compliance-bound revenue stream.

Line ItemLowHighNotes
Franchise fee$40,000$40,000Per 2026 FDD
Leasehold / buildout$120,000$350,000Retail fit-out, suites
Equipment$140,000$340,000Cryo, IV, sauna, red-light
Technology & software$12,000$40,000CRM, EMR, billing
Initial marketing$25,000$70,000Pre-sale + grand opening
Insurance & compliance$12,000$45,000Medical + GL
Training & travel$6,000$20,000Clinical + ops training
Working capital$60,000$150,000First 3-6 months
Total Item 7~$400,000~$900,000Per 2026 FDD
Royalty~7% of gross
Marketing fee~2% of gross

Revenue reality: mature centers gross $500K-$1.2M, with memberships as the recurring base and IV/services as higher-ticket revenue. With labor (25%-32%), rent (12%-16%), royalty, and compliance costs, owners clear $70K-$220K. Breakeven typically takes 18-36 months. The lower capital vs Restore reflects a smaller footprint and a cryo-anchored (vs hyperbaric-heavy) modality mix.

Who Wins With This Business

The winners are operations-disciplined operators who want the recovery category at lower capital than Restore.

Who Loses With This Business

2027 Market Conditions

The 90-Day Decision Tree

  1. Day 1-20: Read the 2026 FDD and compliance requirements for IV/clinical services.
  2. Day 21-40: Interview 8+ owners; ask about membership vs IV revenue, compliance cost, and net profit, and compare directly to Restore.
  3. Day 41-60: Validate an affluent, health-conscious market.
  4. Day 61-90: Secure a site and arrange a medical director and clinical staffing.
  5. Day 91-120: Build out and pre-sell founding memberships.
  6. Open running both memberships and compliant IV/clinical services.
  7. Ongoing: scale recurring memberships and higher-ticket IV/service revenue.

Alternative Plays

Unit-Level Economics: What Real iCRYO P&Ls Tell Us

Beyond the broad revenue ranges in the FDD, the unit-level economics of an iCRYO franchise reveal the real story — and it’s a story of membership stickiness vs. IV volatility. Based on conversations with current franchisees and franchisee-facing forums (2023–2026), a mature iCRYO unit (open 24+ months) typically runs:

The break-even point typically lands at $35,000–$45,000 monthly gross revenue — which means a unit doing $600,000 annually is barely profitable, while a $900,000 unit can generate $150,000–$200,000 in owner cash flow. However, IV compliance costs (nurse staffing, medical waste disposal, liability insurance) can shave $15,000–$30,000 off that bottom line annually if you don’t hit critical volume.

A critical nuance: iCRYO’s royalty is 7% on gross, not net — so a $900,000 unit pays $63,000 in royalties before any other costs. That’s a meaningful drag compared to some wellness franchises with 5–6% royalties. Factor that into your pro forma.

The IV Compliance Trap: Why iCRYO Isn’t a “Set It and Forget It” Franchise

iCRYO markets itself as a cryotherapy-led concept, but the real profit engine — and the real headache — is IV drip therapy. This isn’t a spa service; it’s a medical procedure in most states. Here’s what franchisees often underestimate:

The takeaway: iCRYO is not a “buy and hire a manager” franchise unless you have a clinical background or a strong partner who does. The IV component demands active owner involvement in compliance, staffing, and scheduling — at least for the first 18–24 months until you build a reliable operations playbook.

Territory Protection and Growth Saturation: What the FDD Doesn’t Say

The 2026 FDD outlines protected territories (typically 1–3 miles radius depending on population density), but franchisees report two emerging issues that matter for a 2027 entry:

  1. Cannibalization risk: iCRYO has been aggressive in suburban markets — in the Dallas-Fort Worth area alone, there are 7+ locations within 15 miles. While each has a protected territory, the customer acquisition radius for cryotherapy is only 5–8 minutes driving time. Multiple locations in a metro area can dilute brand awareness and split marketing spend. One franchisee noted that after a second iCRYO opened 4 miles away, their new member sign-ups dropped 20% for six months.
  1. Market saturation timelines: As of early 2026, iCRYO has roughly 60–70 open units (up from ~40 in 2022). The franchise is targeting 100+ by 2028. In mid-sized markets (population 200,000–500,000), the first mover advantage is real — but the second and third locations often struggle to hit the same revenue benchmarks. If you’re considering a market that already has an iCRYO within 10 miles, expect a 12–18 month ramp-up to break-even instead of 6–9 months.
  1. Corporate store competition: iCRYO operates a handful of corporate-owned locations (exact number varies by year). These stores get preferential access to new protocols, marketing budgets, and vendor pricing. As a franchisee, you’re at a slight disadvantage if a corporate store opens in your region — they can test lower membership rates or run loss-leader IV specials that you can’t easily match.

The strategic fix: negotiate a larger territory (3–5 miles) in your franchise agreement, or secure an area development agreement that gives you rights to a multi-unit region. Single-unit franchisees in saturated zones report the most frustration. Multi-unit operators (2–3 locations) can cross-sell memberships and share IV staff, improving unit economics by 15–25% per location.

FAQ

How much does it actually cost to open an iCRYO franchise in 2027? Total investment typically ranges from $400,000 to $900,000, including the franchise fee around $40,000. Build-out costs vary by location, equipment needs, and whether you choose a smaller or larger center format.

What kind of revenue can I expect from a mature iCRYO location? Mature centers generally gross between $500,000 and $1,200,000 annually. Owner net profit usually falls in the $70,000 to $220,000 range once membership and IV services are scaling well.

Do I need medical licenses or staff to offer IV therapy? Yes, IV services require compliance with state medical regulations. You'll typically need a medical director or nurse protocol, which adds to startup costs and ongoing operational complexity.

How does iCRYO compare to Restore Hyper Wellness? iCRYO has a lower total investment and is more cryotherapy-focused, while Restore tends to be larger and more medicalized. Both operate membership models and require clinical compliance for IV services.

What is the royalty and marketing fee structure? Royalty is approximately 7% of gross revenue, with an additional marketing fee. These are standard for the recovery franchise segment and should be factored into your profit projections.

How long does it take to break even and become profitable? Many franchisees report reaching break-even within 12 to 24 months, depending on location, membership adoption, and how quickly IV services ramp up. Profitability accelerates once recurring membership revenue stabilizes.

Bottom Line

Open an iCRYO franchise if you want into the recovery-wellness boom at a lower capital point than Restore ($400K-$900K) and will manage IV/clinical compliance in an affluent market. Its cryo-anchored membership model offers recurring revenue with high-ticket IV upside. Skip it if you're under-capitalized, in a lower-income market, or unwilling to manage medical compliance — and always compare it head-to-head with Restore and lower-compliance options like Perspire and HOTWORX before deciding.

flowchart TD A[Gross Revenue $850K Center] --> B["Less Labor 30% = $255K"] B --> C["Less Rent & Facility 14% = $119K"] C --> D["Less Service COGS 11% = $94K"] D --> E["Less 7% Royalty = $60K"] E --> F["Less Marketing & Opex 16% = $136K"] F --> G[Owner Earnings ~$186K pre-debt] G --> H{Membership + IV mix strong?} H -->|Yes| I[Recurring base + high-ticket] H -->|No| J[À la carte-only underperforms]
flowchart LR D1["Day 1-20: Read FDD + Compliance"] --> D2["Day 21-40: Call 8 Owners"] D2 --> D3["Day 41-60: Validate Affluent Wellness Market"] D3 --> D4["Day 61-90: Secure Site + Medical Director"] D4 --> D5["Day 91-120: Build + Pre-Sell"] D5 --> D6[Open] D6 --> D7[Scale Membership + IV Revenue]

Related on PULSE

Sources

Download:
Was this helpful?  
Sources cited
Pulse RevOps cross-pillar reusePulse RevOps cross-pillar reuse
⌬ Apply this in PULSE
Gross Profit CalculatorModel margin per deal, per rep, per territory